Clinical study COLCOT-T2D :

Clinical study COLCOT-T2D :

Prevention of heart disease in people with type 2 diabetes

Clinical study COLCOT-T2D :

Prevention of heart disease in people with type 2 diabetes

50px
Bloc text

Recruitment has begun! Contact us now.

1-877-587-3389

EVALUATE MY POTENTIAL ELIGIBILITY

50px
Bloc text

The FDA has approved colchicine for the prevention of cardiovascular events in individuals with a pre-existing heart condition, using data from the COLCOT study conducted by the Montreal Heart Institute with the MHICC. The COLCOT-T2D study will assess whether colchicine also works in primary prevention for type 2 diabetics who do not have coronary heart disease.

Click here to read the article in the Financial Post.

50px
Bloc text

Are you eligible to take part in this study?

See more

 

 

 

50px